(Q36523265)

14 August 2017

1 reference

title

Second-generation antipsychotics: is there evidence for sex differences in pharmacokinetic and adverse effect profiles? (English)

1 reference

14 August 2017

1 reference

Wolfgang Aichhorn

1

1 reference

14 August 2017

Alexandra B Whitworth

series ordinal

2

1 reference

14 August 2017

Elisabeth M Weiss

series ordinal

3

1 reference

14 August 2017

Josef Marksteiner

series ordinal

4

1 reference

14 August 2017

publication date

1 January 2006

1 reference

14 August 2017

1 reference

14 August 2017

volume

29

1 reference

14 August 2017

issue

7

1 reference

14 August 2017

page(s)

587-598

1 reference

https://scigraph.springernature.com/pub.10.2165/00002018-200629070-00004

14 August 2017

exact match

0 references

cites work

Effects of Gender and Age on Plasma Levels of Clozapine and Its Metabolites

1 reference

https://api.crossref.org/works/10.2165%2F00002018-200629070-00004

Age at onset and gender of schizophrenic patients in relation to neuroleptic resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002018-200629070-00004

Sexuality, reproduction, and family planning in women with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002018-200629070-00004

Decreased bone mineral density in medicated psychiatric patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002018-200629070-00004

Sex hormones prolong the QT interval and downregulate potassium channel expression in the rabbit heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002018-200629070-00004

Identifying risk factors for tardive dyskinesia among long-term outpatients maintained with neuroleptic medications. Results of the Yale Tardive Dyskinesia Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002018-200629070-00004

Gender differences in tardive dyskinesia: a critical review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002018-200629070-00004

Antipsychotic-related QTc prolongation, torsade de pointes and sudden death

21 January 2018

1 reference

12 December 2020

Factors influencing acute weight change in patients with schizophrenia treated with olanzapine, haloperidol, or risperidone

1 reference

12 December 2020

Gender differences in the prescribing of antipsychotic drugs

1 reference

12 December 2020

Mechanism of the cardiotoxic actions of terfenadine

1 reference

12 December 2020

CYP2D6 and CYP2C19 activity in a large population of Dutch healthy volunteers: indications for oral contraceptive-related gender differences

1 reference

12 December 2020

Relationship between levels of insulin or triglycerides and serum concentrations of the atypical antipsychotics clozapine and olanzapine in patients on treatment with therapeutic doses

1 reference

12 December 2020

How many women have osteoporosis now?

1 reference

12 December 2020

Association of olanzapine-induced weight gain with an increase in body fat.

1 reference

12 December 2020

Risperidone versus haloperidol in the treatment of chronic schizophrenic inpatients: a multicentre double-blind comparative study

1 reference

12 December 2020

Ziprasidone and the QTc interval: pharmacokinetic and pharmacodynamic considerations

1 reference

12 December 2020

Lower risk for tardive dyskinesia associated with second-generation antipsychotics: a systematic review of 1-year studies

1 reference

12 December 2020

Biologic and molecular mechanisms for sex differences in pharmacokinetics, pharmacodynamics, and pharmacogenetics: Part I.

1 reference

12 December 2020

Effects of gender on cardiac arrhythmias.

1 reference

12 December 2020

How important are gender differences in pharmacokinetics?

1 reference

12 December 2020

Risk of proarrhythmia with class III antiarrhythmic agents: sex-based differences and other issues

1 reference

12 December 2020

Concomitant use of antipsychotics and drugs that may prolong the QT interval

1 reference

12 December 2020

The association of weight gain and olanzapine plasma concentrations.

1 reference

12 December 2020

Sex and racial differences in pharmacological response: where is the evidence? Pharmacogenetics, pharmacokinetics, and pharmacodynamics

1 reference

12 December 2020

Is gender a risk factor for adverse drug reactions? The example of drug-induced long QT syndrome

1 reference

12 December 2020

Osteoporosis in patients with schizophrenia

1 reference

12 December 2020

Antipsychotic drugs: a new risk factor for osteoporosis in young women with schizophrenia?

1 reference

12 December 2020

Increasing prevalence of the metabolic syndrome among u.s. Adults.

1 reference

12 December 2020

Antipsychotic-induced hyperprolactinaemia in women: pathophysiology, severity and consequences. Selective literature review

1 reference

12 December 2020

Influence of age, gender, body weight and valproate comedication on quetiapine plasma concentrations

1 reference

12 December 2020

Clinical predictors of response to clozapine treatment in ambulatory patients with schizophrenia.

1 reference

12 December 2020

Serum leptin and triglyceride levels in patients on treatment with atypical antipsychotics.

1 reference

12 December 2020

Prolactin levels and adverse events in patients treated with risperidone.

1 reference

12 December 2020

The reproductive safety profile of mood stabilizers, atypical antipsychotics, and broad-spectrum psychotropics.

1 reference

12 December 2020

Changes in body mass index for individuals with and without schizophrenia, 1987–1996

1 reference

12 December 2020

An exploratory haloperidol-controlled dose-finding study of ziprasidone in hospitalized patients with schizophrenia or schizoaffective disorder

1 reference

12 December 2020

Extrapyramidal side effects are unacceptable

1 reference

12 December 2020

Does fast dissociation from the dopamine d(2) receptor explain the action of atypical antipsychotics?: A new hypothesis

1 reference

12 December 2020

Transfer of risperidone and 9-hydroxyrisperidone into human milk

1 reference

12 December 2020

Clozapine use in two full-term pregnancies

1 reference

12 December 2020

Clinical utilization of atypical antipsychotics in pregnancy and lactation

1 reference

12 December 2020

The effects of hormones on arrhythmias in women.

1 reference

12 December 2020

1 reference

12 December 2020

Physical health monitoring of patients with schizophrenia

1 reference

12 December 2020

Gender differences in psychotropic drug metabolism

1 reference

12 December 2020

Quantification of intraindividual variability and the influence of menstrual cycle phase on CYP2D6 activity as measured by dextromethorphan phenotyping.

1 reference

12 December 2020

The effects of gender, age, ethnicity, and liver cirrhosis on cytochrome P450 enzyme activity in human liver microsomes and inducibility in cultured human hepatocytes

1 reference

12 December 2020

Olanzapine induces insulin resistance: results from a prospective study

1 reference

12 December 2020

Prevalence of diabetes mellitus among outpatients with severe mental disorders receiving atypical antipsychotic drugs

1 reference

12 December 2020

Quetiapine serum concentrations in psychiatric patients: the influence of comedication

1 reference

12 December 2020

Management of sexual dysfunction in patients with cardiovascular disease: recommendations of The Princeton Consensus Panel.

1 reference

12 December 2020

1 reference

12 December 2020

A Target-Dose Finding Study of Clozapine in Patients with Schizophrenia

1 reference

12 December 2020

Rate of new-onset diabetes among patients treated with atypical or conventional antipsychotic medications for schizophrenia

1 reference

12 December 2020

Interactions between the cytochrome P450 system and the second-generation antipsychotics

1 reference

12 December 2020

A randomized evaluation of the effects of six antipsychotic agents on QTc, in the absence and presence of metabolic inhibition

1 reference

12 December 2020

The effects of antipsychotic-induced hyperprolactinaemia on the hypothalamic-pituitary-gonadal axis

1 reference

12 December 2020

Comparison of sexual dysfunction in male schizophrenic patients maintained on treatment with classical antipsychotics versus clozapine

1 reference

12 December 2020

Excretion of quetiapine in breast milk

1 reference

12 December 2020

Olanzapine excretion in human breast milk: estimation of infant exposure.

1 reference

12 December 2020

Transfer of olanzapine into breast milk, calculation of infant drug dose, and effect on breast-fed infants

1 reference

12 December 2020

Gender differences in the proarrhythmic potential of QT-prolonging drugs

1 reference

12 December 2020

Sex differences in schizophrenia, a review of the literature

1 reference

12 December 2020

Effects of gender and age on plasma levels of clozapine and its metabolites: analyzed by critical statistics

1 reference

12 December 2020

Pharmacokinetics of sertindole in healthy young and elderly male and female subjects.

1 reference

12 December 2020

Consensus development conference on antipsychotic drugs and obesity and diabetes

1 reference

12 December 2020

Aripiprazole in the treatment of schizophrenia: safety and tolerability in short-term, placebo-controlled trials

1 reference

12 December 2020

Influence of gender and oral contraceptives on CYP2D6 and CYP2C19 activity in healthy volunteers

1 reference

12 December 2020

Risperidone treatment of outpatients with schizophrenia: no evidence of sex differences in treatment response

1 reference

12 December 2020

Clozapine occupies high levels of dopamine D2 receptors

1 reference

12 December 2020

Bodyweight gain associated with atypical antipsychotics: epidemiology and therapeutic implications

1 reference

12 December 2020

Double-blind comparison of olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders.

1 reference

12 December 2020

Influence of dose, cigarette smoking, age, sex, and metabolic activity on plasma clozapine concentrations: a predictive model and nomograms to aid clozapine dose adjustment and to assess compliance in individual patients

1 reference

12 December 2020

Relationship between antipsychotic medication treatment and new cases of diabetes among psychiatric inpatients

1 reference

12 December 2020

Ziprasidone and the activity of cytochrome P450 2D6 in healthy extensive metabolizers

1 reference

12 December 2020

Prolactin levels in schizophrenia and schizoaffective disorder patients treated with clozapine, olanzapine, risperidone, or haloperidol.

1 reference

12 December 2020

Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder.

1 reference

12 December 2020

Atypical antipsychotic drugs and diabetes mellitus in a large outpatient population: a retrospective cohort study

1 reference

12 December 2020

Pregnancy outcome of women using atypical antipsychotic drugs: a prospective comparative study.

1 reference

12 December 2020

Risperidone distribution and excretion into human milk: case report and estimated infant exposure during breast-feeding

1 reference

12 December 2020

Relationship between dopamine D(2) occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia

1 reference

12 December 2020

Weight gain, serum leptin and triglyceride levels in patients with schizophrenia on antipsychotic treatment with quetiapine, olanzapine and haloperidol

1 reference

12 December 2020

Prolactin and antipsychotic medications: mechanism of action

1 reference

12 December 2020

Biologic and molecular mechanisms for sex differences in pharmacokinetics, pharmacodynamics, and pharmacogenetics: Part II.

1 reference

12 December 2020

Hyperprolactinemia after low dose of amisulpride.

1 reference

12 December 2020

Hyperprolactinaemia and antipsychotic therapy in schizophrenia

1 reference

12 December 2020

Sexual side effects of novel antipsychotic medications

1 reference

12 December 2020

The increase in risk of diabetes mellitus from exposure to second-generation antipsychotic agents.

1 reference

12 December 2020

Different influences of classical antipsychotics and clozapine on glucose-insulin homeostasis in patients with schizophrenia or related psychoses.

1 reference

12 December 2020

Therapeutic drug monitoring of olanzapine: the combined effect of age, gender, smoking, and comedication

1 reference

12 December 2020

Pregnancy of a patient treated with clozapine

1 reference

12 December 2020

Gender differences in pharmacokinetics and pharmacodynamics

1 reference

12 December 2020

Sex-based differences in the effect of digoxin for the treatment of heart failure

1 reference

12 December 2020

Dopamine antagonists and the development of breast cancer

1 reference

12 December 2020

Neuroleptic drug-induced extrapyramidal syndromes and tardive dyskinesia

1 reference

12 December 2020

Relationship between patient variables and plasma clozapine concentrations: a dosing nomogram.

1 reference

12 December 2020

Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review

1 reference

12 December 2020

Antipsychotic-induced weight gain: a comprehensive research synthesis

1 reference

12 December 2020

Antipsychotics: impact on prolactin levels

1 reference

12 December 2020

Therapeutic drug monitoring data on olanzapine and its N-demethyl metabolite in the naturalistic clinical setting

1 reference

12 December 2020

The pharmacology of weight gain with antipsychotics.

1 reference

12 December 2020

Healthy outcome under olanzapine treatment in a pregnant woman.

1 reference

12 December 2020

Effects of long-term prolactin-raising antipsychotic medication on bone mineral density in patients with schizophrenia.

1 reference

12 December 2020

Weight gain: side effect of atypical neuroleptics?

1 reference

12 December 2020

Sexual dysfunction in patients taking conventional antipsychotic medication

1 reference

12 December 2020

Safety and tolerability: how do newer generation "atypical" antipsychotics compare?

1 reference

12 December 2020

Weight gain in patients with schizophrenia treated with risperidone, olanzapine, quetiapine or haloperidol: results of the EIRE study

1 reference

12 December 2020

The D2 dopamine receptor occupancy of risperidone and its relationship to extrapyramidal symptoms: a PET study.

1 reference

12 December 2020

A randomized open-label study of the impact of quetiapine versus risperidone on sexual functioning

1 reference

12 December 2020

Clozapine and pregnancy

1 reference

12 December 2020

Pharmacokinetics of the novel antipsychotic agent risperidone and the prolactin response in healthy subjects.

1 reference

12 December 2020

A study of serum prolactin levels in schizophrenia: comparison of males and females

1 reference

12 December 2020

Schizophrenia and the risk for breast cancer

1 reference

12 December 2020

Risperidone and breast-feeding

1 reference

12 December 2020

JTc prolongation with d,l-sotalol in women versus men

1 reference

12 December 2020

Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III.

1 reference

12 December 2020

Differential olanzapine plasma concentrations by sex in a fixed-dose study

1 reference

12 December 2020

Effects of olanzapine on prolactin levels of female patients with schizophrenia treated with risperidone

1 reference

12 December 2020

Antipsychotic-induced hyperprolactinaemia: mechanisms, clinical features and management

1 reference

12 December 2020

Risperidone side effects.

1 reference

12 December 2020

Effects of age and sex on olanzapine plasma concentrations

1 reference

12 December 2020

Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs

1 reference

12 December 2020

Olanzapine. Pharmacokinetic and pharmacodynamic profile.

1 reference

12 December 2020

Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo. A meta-analysis of randomized controlled trials

1 reference

12 December 2020

Antipsychotic-induced hyperprolactinemia and sexual dysfunction.

1 reference

12 December 2020

Gender differences in neuroleptic nonresponsive clozapine-treated schizophrenics.

1 reference

12 December 2020

Influence of age and gender on risperidone plasma concentrations

1 reference

12 December 2020

Temporal changes in drug metabolism (CYP1A2, CYP2D6 and CYP3A Activity) during pregnancy

1 reference

12 December 2020

Hyperprolactinemia in response to antipsychotic drugs: characterization across comparative clinical trials

1 reference

12 December 2020

10.2165/00002018-200629070-00004

Identifiers

DOI

1 reference

Dimensions Publication ID

14 August 2017

1045652242

0 references

1 reference